Director, Project Management

Location: Princeton, NJ ONSITE
About Summit
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit's Team Is Inspired To Touch And Help Change Lives Through Summit's Clinical Studies In The Field Of Oncology. Summit Has Multiple Global Phase 3 Clinical Studies, Including
Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
  

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
  

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China's National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview Of Role
The Director, Project Management (PM) will serve as a critical leader in driving the cross-functional planning, integration, and execution of all activities required for the successful commercialization of the company's first oncology product. This individual will partner closely with Commercial, Medical, Regulatory, Market Access, Supply Chain, Finance, and other internal functions to build and maintain comprehensive launch plans, ensure alignment on readiness milestones, and proactively identify and resolve risks and dependencies.
The ideal candidate brings extensive launch experience, exceptional cross-functional leadership skills, and the ability to operate with agility in a dynamic, high-growth environment.
Role And Responsibilities

• Drive the global manufacturing and technical operations strategy and deliverables, ensuring alignment with corporate objectives and long-term growth plans.
• Lead the development, integration, and ongoing management of the end-to-end launch plan for the company's oncology product.
• Establish launch governance structures, including workstreams, steering committees, and communication frameworks.
• Track progress against launch milestones, KPIs, and critical path activities; proactively identify risks, gaps, and mitigation strategies.
• Ensure alignment between clinical, regulatory, commercial, medical affairs, and supply chain functions throughout the launch cycle.
• Facilitate effective communication and collaboration among all launch workstreams and senior leaders.
• Report metrics and drive decision-making by preparing executive-level presentations, scenario analyses, and status updates.
• Partner with functional heads to ensure integration of commercial strategies, medical strategies, distribution planning, pricing and market access activities, and compliance considerations.
• Support organizational readiness by coordinating training, process development, and infrastructure build-out across functions.
• Work closely with Commercial leadership to align timelines and dependencies across brand strategy, field force planning, marketing, and market access activities.
• Ensure launch planning incorporates patient services, distribution models, safety requirements, and external stakeholder engagement.
• Support development of the comprehensive launch readiness dashboard and reporting tools
• All other duties as assigned.
  

Experience, Education And Specialized Knowledge And Skills

• Bachelor's degree in a scientific or business-related field; advanced degree (MBA, MS, PharmD) preferred.
• Minimum of 10+ years of project or program management experience in the pharmaceutical/biotechnology industry.
• Proven track record leading commercialization and launch activities, preferably in oncology or specialty therapeutics.
• Strong understanding of pre-commercial and launch-stage requirements, including commercial, medical, regulatory, supply chain, and market access functions.
• Demonstrated ability to drive complex, cross-functional programs in fast-paced, high-growth environments.
• Exceptional communication, leadership, facilitation, and consensus-building skills.
• Expertise in project management tools, frameworks, and methodologies.
  

The pay range for this role is $184,000-$230,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit's Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.